Text
Rescue medicine vs prevention
Screening is not about expecting bad news. It is about reducing uncertainty, and giving you and your clinician more options while there are more options to have.
Dr. Scott Tackett
President & CEO
Earlier detection deserves the same operational focus.
Closing the evidence-to-practice gap isn’t only about developing better technology.
It’s about designing healthcare systems that make earlier detection solutions easier to adopt, integrate and sustain in routine clinical practice.
Because innovation creates possibility.
Implementation creates impact.
Originally shared on LinkedIn
Join the conversation and see how others have responded.
Advancing infrared applications for earlier detection — beginning with lung cancer.
AIR-DS is a UKCA marked in vitro diagnostic medical device, developed in accordance with IEC 62304 and under an ISO 13485 certified quality management system. In the US, a CLIA certified laboratory will offer a laboratory developed test (LDT) with AIR-DS Lung Test. It has not been cleared or approved by the FDA. Information on this website is provided for educational and informational purposes and should not be interpreted as medical advice.